Atlantic Edge Private Wealth Management’s Revolution Medicines RVMD Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87K	Buy	+10	New	+$1.46K	﹤0.01%	566

Other funds holding RVMD

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

APM

a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return

Atlantic Edge Private Wealth Management's RVMD Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 10 shares worth $1.87K. The stake represents ﹤0.01% of the portfolio and ranks #566 among its holdings.

165 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Atlantic Edge Private Wealth Management held 10 shares of Revolution Medicines worth $1.87K as of Q2 2026.
Revolution Medicines was a new Atlantic Edge Private Wealth Management position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #566 holding.
165 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.